ES403542A1 - Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation - Google Patents

Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation

Info

Publication number
ES403542A1
ES403542A1 ES403542A ES403542A ES403542A1 ES 403542 A1 ES403542 A1 ES 403542A1 ES 403542 A ES403542 A ES 403542A ES 403542 A ES403542 A ES 403542A ES 403542 A1 ES403542 A1 ES 403542A1
Authority
ES
Spain
Prior art keywords
formula
group
preparation
compound
chr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES403542A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES403542A1 publication Critical patent/ES403542A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedure for the preparation of compounds of the formula **(See formula)** wherein R is hydrogen, an alcohol or lower alkoxy group, or a halogen atom; R'means one of the groups, in the target positions or for -CHR1-Q-A, -CHR2-A and -O-CHR2-CHR1-Q-A, where A represents radicals **(See formula)** Q means a branched or unbranched alcoholic chain with 1 to 4 carbon atoms, R1 means the hydrogen atom, the hydroxy group, a lower alkoxy group or the group -Q-CO-R5, R2 means the hydrogen atom or the methyl group, R3 and R4, which may be the same or different, represent the hydrogen atom, an alcohol or lower alkoxy group, a halogen atom or the trifluoromethyl group, or together also a 5- or 6-membered ring, aliphatic or aromatic, adjacent condensed, R5 signifies a lower alcohol group, which may be substituted by halogen, hydroxy or alkoxy, the amino group or a monoalkoxylamino or dialcoylamino group, Z means an aromatic ring with 1 to 2 heteroatoms, with which it can also be adjacently fused a benzene ring, and in which R'' designates the hydrogen atom or an alcoholic, alkenyl, alkynyl, hydroxyalkoxy, dialkoylaminoalkoxy or lower aralkoxy radical, branched or unbranched, as well as the corresponding acid addition salts, characterized in that a) an amine of the formula is reacted H-A (II) with a compound of the formula **(See formula)** where Ra represents one of the groups, in the meta positions or for -CHR2-X, -CHR1-Q-X and -O-CHR2-CHR1-Q-X in which X means a radical capable of being separated with the hydrogen from the compound HA in the form of HX, in the presence of an HX fixing agent; or because b) for the preparation of the compounds according to the invention in which R1 signifies the hydrogen atom, the hydroxy group or a lower alkoxy group, a ring closure is carried out in a corresponding compound of the formula **(See formula)** or because c) for the preparation of the compounds of formula I, in which R'' does not represent a hydroxyalkyl radical, R1 does not represent the hydroxy group and R5 does not represent a hydroxyalkyl radical, the amino group or a monoalkoxy amino group, a ring closure is performed on ethylene diamine derivatives of the formula **(See formula)** with appropriate carbonic acid derivatives or with metal cyanates in the presence of acids; or because d) for the preparation of the compounds according to the invention in which A designates the radical **(See formula)** a compound of the formula is subjected to reductive amination **(See formula)** where Rb means one of the groups, in the target positions or for -CHO, -CHR1-CnH2n-1O and -O-CHR2-CHR1-CnH2n-1O (n equal to 1, 2, 3 or 4), with an amine of the formula HA; or because e) for the preparation of the compounds of the formula I, in which R'means the radical -CHOH-Q-A, ketones of the formula are reduced **(See formula)** or because f) for the preparation of the compounds of the formula I, in which it means hydrogen and R'' means a radical R''1, the OH group is removed from a compound of the formula **(See formula)** in which R''1 signifies an alcoholic, alkoxyalkoyl or lower aralkoyl radical and R0 represents one of the radicals, in the meta or para positions of the formula -CR2OH-A, -CHOH-Q-A or -O-CHR2-CHOH-Q-A or because, g) for the preparation of the compounds of the general formula I, in which R1 signifies the hydroxy group, a compound of the formula is reacted **(See formula)** where Rd means one of the radicals, in the meta or para positions, of the formulas **(See formula)** wherein R6 and R7 signify hydrogen or alcohol radicals having together up to 3 carbon atoms, with an amine of the formula H-A; or because h) for the preparation of the compounds of the formula I, in which R1 represents the hydrogen atom, a lower alkoxy group or the group -O-CO-R5, in which R5 is an alcoholic or alkoxyalcoyl group or a dialkoxylamino group, a compound of the formula is reacted **(See formula)** where R'has the preceding meanings, limited as regards R1, and Me + signifies an alkali metal cation, with a corresponding compound R''X; or why i) for the preparation of compounds of formula I, in which R'represents the radical -O-CHR2-CH2-Q-A a phenol of the formula is reacted **(See formula)** wherein the phenolic OH group is in the meta or para positions, with a compound of the formula X-CHR2-CH2-Q-A in the presence of an acid binding agent; or because k) for the preparation of compounds of the formula I, in which R1 signifies an alkoxy group or a group -O-CO-R5 and R'' does not signify the hydroxyalkyl group, a compound of the formula is reacted **(See formula)** where Re represents one of the radicals in meta positions or for -CHOH-Q-A or -O-CHR2-CHOH-Q-A with an agent to replace the hydrogen of the OH by means of an alcoholic group or with a group -CO-R5; and because eventually the bases, obtained primarily according to the process modes a) to k), are transformed into acid addition salts, the acid addition salts, obtained primarily in said procedures, are transformed into free bases, and/or eventually a doubling is carried out into diastereoisomers or optical antipodes. (Machine-translation by Google Translate, not legally binding)
ES403542A 1971-06-07 1972-06-06 Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation Expired ES403542A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT492071A AT311956B (en) 1971-06-07 1971-06-07 Process for the preparation of new phenylimidazolidinone derivatives and their salts

Publications (1)

Publication Number Publication Date
ES403542A1 true ES403542A1 (en) 1975-05-01

Family

ID=3569889

Family Applications (1)

Application Number Title Priority Date Filing Date
ES403542A Expired ES403542A1 (en) 1971-06-07 1972-06-06 Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation

Country Status (20)

Country Link
AR (7) AR200112A1 (en)
AT (1) AT311956B (en)
AU (1) AU473287B2 (en)
BE (1) BE784475A (en)
BG (1) BG22822A3 (en)
CA (1) CA1011336A (en)
CH (7) CH591475A5 (en)
DD (1) DD101403A5 (en)
DE (1) DE2223751A1 (en)
ES (1) ES403542A1 (en)
FR (1) FR2140492B1 (en)
GB (1) GB1391491A (en)
HU (1) HU165493B (en)
IE (1) IE37812B1 (en)
IL (1) IL39620A (en)
NL (1) NL7207701A (en)
NO (1) NO136841C (en)
SE (1) SE392902B (en)
SU (8) SU453839A3 (en)
ZA (1) ZA723840B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822678A1 (en) * 1998-05-20 1999-11-25 Bayer Ag New 1,3-diaza-2-oxo-cycloalkane derivatives, useful as pre- or post-emergence, total or selective herbicides
WO2004106292A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
WO2004106291A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
RU2497810C1 (en) * 2012-06-28 2013-11-10 Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" Method of obtaining n,n-diaryl-substituted 2-trichloromethyl-imidazolidines

Also Published As

Publication number Publication date
AR202904A1 (en) 1975-07-31
BG22822A3 (en) 1977-04-20
AR203017A1 (en) 1975-08-08
IL39620A (en) 1977-02-28
IE37812L (en) 1972-12-07
CH589645A5 (en) 1977-07-15
IL39620A0 (en) 1972-08-30
CH591475A5 (en) 1977-09-15
SU503516A3 (en) 1976-02-15
SU453839A3 (en) 1974-12-15
AU4312972A (en) 1973-12-13
AR200112A1 (en) 1974-10-24
GB1391491A (en) 1975-04-23
SU493067A3 (en) 1975-11-25
SU498907A3 (en) 1976-01-05
BE784475A (en) 1972-12-06
CH583729A5 (en) 1977-01-14
SU505358A3 (en) 1976-02-28
SU499806A3 (en) 1976-01-15
AU473287B2 (en) 1973-12-13
NO136841B (en) 1977-08-08
SU492085A3 (en) 1975-11-15
CH573425A5 (en) 1976-03-15
ZA723840B (en) 1974-02-27
AR205522A1 (en) 1976-05-14
NL7207701A (en) 1972-12-11
CH590269A5 (en) 1977-07-29
SE392902B (en) 1977-04-25
CA1011336A (en) 1977-05-31
SU509228A3 (en) 1976-03-30
CH589644A5 (en) 1977-07-15
FR2140492B1 (en) 1976-03-05
HU165493B (en) 1974-09-28
FR2140492A1 (en) 1973-01-19
NO136841C (en) 1977-11-16
AT311956B (en) 1973-12-10
AR207109A1 (en) 1976-09-15
DE2223751A1 (en) 1972-12-28
DD101403A5 (en) 1973-11-05
AR200139A1 (en) 1974-10-24
AR202903A1 (en) 1975-07-31
CH589646A5 (en) 1977-07-15
IE37812B1 (en) 1977-10-26

Similar Documents

Publication Publication Date Title
ES403542A1 (en) Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation
ES2037779T3 (en) PROCEDURE FOR PREPARING NEW AMIDA COMPOUNDS.
ES450995A1 (en) 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof
ES493599A0 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF AZETI DIN-2-ONA.
US2376112A (en) Amination of dihydric phenols
ES418827A1 (en) 2-aminoindane derivatives
GB2021559A (en) Benzylidene derivatives
ES378202A1 (en) 2-(imidazolid inylidence-(2)-amino)-5-nitro-thiazoles and salts thereof
DE69015208D1 (en) DERIVATIVES OF GLUTAMINE AND ASPARGINIC ACID WITH ANTIGASTRINE EFFECT AND METHOD FOR THE PRODUCTION THEREOF.
EP0145236A3 (en) Thiadiazinone compounds, process for their preparation, and pharmaceutical compositions containing them
PT71598A (en) Process for preparing n-aminoalkyl -indol derivatives
GB1382602A (en) Benzodioxan compounds and process for preparing the same
ES531941A0 (en) PROCEDURE FOR PREPARING AFIDICOLINE DERIVATIVES.
GB1451180A (en) Alkylsulphonylphenoxypropanolamines
Meltsner et al. Alkanolamines. V. Reaction of m-dinitrobenzene with ethanolamines
ES316907A1 (en) A procedure for the manufacture of amino pharmaceutical compounds. (Machine-translation by Google Translate, not legally binding)
ES528460A0 (en) PROCEDURE FOR THE PREPARATION OF NEW ALFA-ETIBENZOL DERIVATIVES WITH A SUBSTITUTED AMINO PROPANOLIC GROUP AND ITS ADDITIONAL SALTS ACID AND QUATERNARY AMMONICS.
ES303423A1 (en) Procedure for the obtaining of new 1-aryloxi-2-hydroxy-3-isopropilamine-propanes and of their salts. (Machine-translation by Google Translate, not legally binding)
ES419548A1 (en) N-(indazolyl-n1-methyl)dialkanolamines
ES411018A2 (en) Derivatives of 4,-aminomethyl-dibenzo-b,e- 11-oxepine-2,- spiro- 1,3, -dioxolane their method of preparation and their thera peutic application
ES393340A1 (en) Amines and a process for the manufacture thereof
MX3332E (en) PROCEDURE FOR THE PREPARATION OF DIPEPTIDE DERIVATIVES
GB835893A (en) New acylamino-compounds and process for their manufacture
ES281441A1 (en) A procedure for the manufacture of pharmaceutical compounds (Machine-translation by Google Translate, not legally binding)
ES484287A1 (en) Procedure for the obtaining of N- (1- (4-amino-2-quinazolinil) -3-0-4-piperidil-lactamas. (Machine-translation by Google Translate, not legally binding)